United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 1, 2026 · Filed May 4, 2026

On May 1, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$570.58 for US$5.42M under a trading plan, leaving 40,513 shares. Filed May 4, 2026 (Form 4).

Sold
9,500 shares
Price
US$570.58 average (US$565.78 to US$571.95)
Value
US$5.42M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 1, 2026Common StockSale200US$565.7849,813Direct
May 1, 2026Common StockSale80US$567.1749,733Direct
May 1, 2026Common StockSale197US$568.3749,536Direct
May 1, 2026Common StockSale843US$569.1848,693Direct
May 1, 2026Common StockSale3,621US$570.2845,072Direct
May 1, 2026Common StockSale3,197US$571.2241,875Direct
May 1, 2026Common StockSale1,362US$571.9540,513Direct

Source

View original at SEC

Related